We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Cardiovascular diseases (CVDs) are one of the leading causes of death and disability in the world
Digital NHS Health Check to be rolled out across England next spring delivering an additional one million checks in the first 4 years.
Update of cardiovascular disease (CVD) profile indicators for stroke data for clinical commissioning groups.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in clinical commissioning groups (CCG) areas.
This document explains the NHS view on private screening for different conditions and diseases.
The profiles provide an overview of data on cardiovascular and cardiovascular related conditions of heart disease, stroke, diabetes and kidney disease. Data will be available for England, integrated care boards and upper tier local authorities where available.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
Advice for medical professionals to follow when assessing drivers with neurological disorders.
You may need to tell DVLA if you have a heart murmur - download the correct form if you need to let them know
You may need to tell DVLA if you have cardiac problems - download the correct form if you need to let them know
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
Projects granted during 2014 that have a primary purpose of basic research into the cardiovascular, blood and lymphatic system.
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.
This is the council’s note about the risk of ischaemic heart disease in work involving exposure to ionising radiation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.